MeSH Browser

MeSH Supplementary: AIEOP protocol 8202
Unique ID: C079188
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C079188
Entry Term(s): AIEOP 8833 protocol; Italian Hematology and Pediatric Oncology Association protocol 8202; intermediate risk ALL 8202 protocol
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Daunorubicin; Methotrexate; Prednisone; Vincristine; Mercaptopurine
Frequency: 2
Note: chemotherapy protocol consisting of above cpds; used in treatment of acute lymphoblastic leukemia (ALL) in children with cystic fibrosis
Source: Haematologica 1992 Sep-Oct;77(5):427-9
Date of Entry: 1993/02/10
Revision Date: 2000/11/30

AIEOP protocol 8202 MeSH Supplementary Concept Data 2023